Irene Jiménez-García

7PUBLICATIONS
67CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthNeonatologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Emapalumab for the Treatment of Peri-Graft Hemophagocytic Lymphohistiocytosis Reactivation in a Patient With Familial Hemophagocytic Lymphohistiocytosis Type 3.

|Aug 14, 2025
Oral and Dental Sequelae After Oncological Treatment in Children: A Systematic Review.

Lidia Torrecillas-Quiles, Inmaculada Gómez-Ríos, Irene Jiménez-García

|Apr 09, 2025
Correction: Management and outcome of children with high‑risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.

Blanca Martínez de Las Heras, Pedro M Rubio-Aparicio, Alba Rubio-San-Simón

|Feb 25, 2025
Management and outcome of children with high-risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease.

Blanca Martínez de Las Heras, Pedro M Rubio-Aparicio, Alba Rubio-San-Simón

|May 04, 2023
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma.

Cécile Thirant, Agathe Peltier, Simon Durand

|Jan 05, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

Pageof 2

Frequent Collaborators

3 joint publications

Mar Bermúdez Cortés

2 joint publications

Hervé J Brisse

2 joint publications

Alba Rubio-San-Simón

2 joint publications

Didier Surdez